ALT5 Sigma Integrates Lightning Network With Voltage To Enable Instant Bitcoin Payments

(MENAFN- FinanceWire) Las Vegas, Nevada, May 27th, 2025, FinanceWire

ALT5 Sigma Corporation (the“Company” or“ALT5”) (NASDAQ:ALTS)(FRA:5AR1), a fintech company providing blockchain-powered payment and trading infrastructure for global merchants and financial institutions, today announced it has enabled Lightning Network payment capabilities through a partnership with Voltage , a leading provider of enterprise-grade Lightning infrastructure.

The integration enables instant, low-cost Bitcoin transactions, meeting the rising demand from businesses for faster settlement, lower fees, and modern payment infrastructure built to scale. As adoption of Lightning accelerates across the financial ecosystem, ALT5 is helping global merchants and financial institutions plug into this next-generation network with the security and scalability they require.

ALT5's clients operate platforms that facilitate high-frequency digital payments, where speed, reliability, and cost-efficiency are essential. Lightning enables them to settle Bitcoin transactions in seconds, delivering an instant experience for end-users while reducing costs and friction at scale. ALT5 continues to see growing demand for faster, lower-cost crypto settlement options, particularly in cross-border and high-frequency transaction environments.

Expanding Horizons: Stablecoins and Real-Time Settlement

The evolving potential for stablecoin settlement over Lightning presents new opportunities for financial platforms. ALT5 is closely monitoring this space as part of its ongoing commitment to delivering scalable, future-ready payment infrastructure for global enterprises.

By embedding Lightning into its broader Crypto-as-a-Service infrastructure, ALT5 continues to support institutions in bridging digital assets with real-world financial workflows securely, efficiently, and across global operations.

For more information on ALT5 Sigma's payment solutions and its integration with Voltage, users can visit

About ALT5 Sigma

Corporation (NASDAQ:ALTS)(FRA:5AR1) is a fintech company, providing next generation blockchain-powered technologies for tokenization, trading, clearing settlement, payment and safe keeping of digital assets. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.

Founded in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation), provides next-generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms to its customers:“ALT5 Pay” and“ALT5 Prime.” ALT5 Sigma has processed over $5 billion USD in cryptocurrency transactions since inception.

ALT5 Pay is an award-winning cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named“ALT5 Pro” that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

The Company is working on the separation of our biotech business that will move forward under“Alyea Therapeutics Corporation.” Through its biotech activities, the Company is focused on bringing to market drugs with non-addictive pain-relieving properties to treat conditions that cause chronic or severe pain. Our patented product, a novel formulation of low-dose naltrexone (JAN123), is being initially developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. The FDA has granted Jan123 Orphan Drug Designation for the treatment of CRPS.

About Voltage

Tags: Bitcoin , Blockchain , Crypto , Exchange , Finance , New , Stocks

MENAFN27052025007843016845ID1109600694